Pharma News

Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way doctors approach treatment.

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), today announced that it has entered into an exclusive license and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a next-generation HER2-targeting antibody drug conjugate (ADC). 

Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. This product would be manufactured at Lupin’s Nagpur facility in India.

The Union Ministry of Health and Family Welfare has removed Montu Patel from his role as President of the Pharmacy Council of India (PCI), citing that he no longer meets the membership requirements to hold office, The Times of India reported.

According to the ministry’s order, “Currently, Patel is neither a nominated member under Section 3(h) of the PCI Act, 1948, nor a member of the Gujarat State Pharmacy Council. Hence he ceases to be a member of the Central Council of PCI, thereby also ending his presidentship.”